title: GlaxoSmithKline pays $3bn to settle dispute over rosiglitazone and other drugs.
authors: Nigel
authors: N
authors: Hawkes
mesh_terms: D034462:Dissent and Disputes; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D007004:Hypoglycemic Agents; D040541:Marketing / Q000331:legislation & jurisprudence*; D000077154:Rosiglitazone; D045162:Thiazolidinediones; D014481:United States; D037041:United States Government Agencies
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone